Differential blood counts of 2 AML patients in remission that carry the variant GFI136N allele
| . | Patient 1 . | Patient 2 . | Normal range . |
|---|---|---|---|
| Leukocytes, 1/fl | 10.9 | 4.5 | 4.5-11 |
| Band granulocytes, % | 0 | 3 | 0-6 |
| Segmented granulocytes, % | 64 | 55 | 40-75 |
| Eosinophils, % | 2 | 1 | 1-7 |
| Lymphocytes, % | 24 | 30 | 22-40 |
| Monocytes, % | 10 | 11 | 1-10 |
| . | Patient 1 . | Patient 2 . | Normal range . |
|---|---|---|---|
| Leukocytes, 1/fl | 10.9 | 4.5 | 4.5-11 |
| Band granulocytes, % | 0 | 3 | 0-6 |
| Segmented granulocytes, % | 64 | 55 | 40-75 |
| Eosinophils, % | 2 | 1 | 1-7 |
| Lymphocytes, % | 24 | 30 | 22-40 |
| Monocytes, % | 10 | 11 | 1-10 |
The presence of the GFI136N allele did not alter hematological parameters in two patients after achieving remission.
AML indicates acute myeloid leukemia; and GFI1, Growth Factor Independence 1.